Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Chongqing Jisrui Pharmaceutical is a pharmaceutical company based in Chongqing, China, and operates as a wholly-owned subsidiary of Chongqing Pharscin Pharmaceutical. The company specializes in the research, development, and large-scale manufacturing of high-end chemical generics and innovative drug formulations. Its modern production facilities in the Rongchang High-tech Zone are designed to meet international GMP standards, supporting a diverse portfolio that includes treatments for digestive, neurological, and respiratory conditions. Jisrui serves as a critical manufacturing and innovation hub for the Pharscin group, facilitating its expansion into both domestic and global pharmaceutical markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Chongqing Jisrui Pharmaceutical.